--- title: "四川港通医疗设备集团股份有限公司 (301515.SZ)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/301515.SZ.md" symbol: "301515.SZ" name: "四川港通医疗设备集团股份有限公司" industry: "医疗器械" --- # 四川港通医疗设备集团股份有限公司 (301515.SZ) | Item | Detail | |------|--------| | Industry | 医疗器械 | | Location | 沪深市场 | | Website | [www.gtjt.com](https://www.gtjt.com) | ## Company Profile 公司是一家现代化的医疗器械研发制造及智慧医疗专业系统整体方案提供商,致力于解决医用气体供应及医疗感染问题,为各类医疗机构提供安全、稳定、高效、智能的生命支持系统和生命支持区域。公司主营业务为医用气体装备及系统、医用洁净装备及系统的研发、设计、制造、集成及运维服务。公司主要产品为医用气体装备及系统、医用洁净装备及系统、医疗设备及其他产品销售、运维服务。公司先后被评为 “中国气体行业领军企业”、“全国医用气体优秀工程企业”、“中国医用气体装备创新基地”、“全国医用气体从业人员培训基地”、“医用气体行业抗疫先进单位”、“四川省行业小巨人企业” 等,公司技术中心被授予 “四川省企业技术中心”,港通商标... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-22T04:30:09.000Z **Overall: D (0.70)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 63 / 63 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -32.70% | | | Net Profit YoY | -124.23% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.11 | | | Dividend Ratio | 0.45% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 2.57B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 606.12M | | **Multi Score**: D #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -1.25% | D | | Profit Margin | -2.61% | D | | Gross Margin | 23.49% | C | #### Growth Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -32.70% | E | | Net Profit YoY | -124.23% | E | | Total Assets YoY | 7.46% | B | | Net Assets YoY | -7.09% | D | #### Cash Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -3827.98% | E | | OCF YoY | -32.70% | E | #### Operating Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.30 | D | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 40.94% | C | ```chart-data:radar { "title": "Longbridge Financial Score - 四川港通医疗设备集团股份有限公司", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-1.25%", "rating": "D" }, { "name": "Profit Margin", "value": "-2.61%", "rating": "D" }, { "name": "Gross Margin", "value": "23.49%", "rating": "C" } ] }, { "name": "Growth", "grade": "E", "indicators": [ { "name": "Revenue YoY", "value": "-32.70%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-124.23%", "rating": "E" }, { "name": "Total Assets YoY", "value": "7.46%", "rating": "B" }, { "name": "Net Assets YoY", "value": "-7.09%", "rating": "D" } ] }, { "name": "Cash", "grade": "E", "indicators": [ { "name": "Cash Flow Margin", "value": "-3827.98%", "rating": "E" }, { "name": "OCF YoY", "value": "-32.70%", "rating": "E" } ] }, { "name": "Operating", "grade": "D", "indicators": [ { "name": "Turnover", "value": "0.30", "rating": "D" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "40.94%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 联影医疗 (SH.688271) | B | B | C | B | B | B | | 02 | 鱼跃医疗 (SZ.002223) | B | B | C | A | C | B | | 03 | 惠泰医疗 (SH.688617) | A | B | B | A | B | B | | 04 | 奕瑞科技 (SH.688301) | A | B | E | A | B | B | | 05 | 振德医疗 (SH.603301) | C | B | C | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -162.01 | 64/66 | 413.72 | 365.55 | 29.63 | | PB | 2.11 | 11/66 | 1.86 | 1.74 | 1.50 | | PS (TTM) | 4.23 | 13/66 | 3.73 | 3.33 | 2.65 | | Dividend Yield | 0.45% | 41/66 | 1.94% | 1.08% | 0.57% | ## References - [Company Overview](https://longbridge.com/en/quote/301515.SZ/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/301515.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/301515.SZ/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.